Tumor‐selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril Hydrochloride

To enhance chemotherapeutic efficacy against cancer, it is important to deliver anticancer drugs preferentially to cancer cells and to retain the drugs there for a prolonged time. The in vivo prolongation of the exposure time of anticancer drugs in tumors can be accomplished by decreasing tumor tiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Hori, Katsuyoshi, Saito, Sachiko, Takahashi, Hiroto, Sato, Haruhiko, Maeda, Hiroshi, Sato, Yasufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2000
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926331/
https://www.ncbi.nlm.nih.gov/pubmed/10761715
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00940.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926331/
https://www.ncbi.nlm.nih.gov/pubmed/10761715
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00940.x

Ejemplares similares